Cysteine Mutations Impair the Structural Stability of Phosphomannomutase 2 (PMM2) in Glycosylation-associated Metabolic Disorders
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Sun W, Guo L, Ye J, Zhou M, Shu C, Ying X Heliyon. 2024; 10(21):e39258.
PMID: 39524749 PMC: 11544054. DOI: 10.1016/j.heliyon.2024.e39258.
Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.
Chen J, Li Z, Wu Y, Li X, Chen Z, Chen P J Mol Neurosci. 2024; 74(4):94.
PMID: 39373898 PMC: 11458684. DOI: 10.1007/s12031-024-02271-x.
References
1.
Poole L
. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med. 2014; 80:148-57.
PMC: 4355186.
DOI: 10.1016/j.freeradbiomed.2014.11.013.
View
2.
Reily C, Stewart T, Renfrow M, Novak J
. Glycosylation in health and disease. Nat Rev Nephrol. 2019; 15(6):346-366.
PMC: 6590709.
DOI: 10.1038/s41581-019-0129-4.
View
3.
Held J
. Redox Systems Biology: Harnessing the Sentinels of the Cysteine Redoxome. Antioxid Redox Signal. 2019; 32(10):659-676.
PMC: 7047077.
DOI: 10.1089/ars.2019.7725.
View
4.
Briso-Montiano A, Del Cano-Ochoa F, Vilas A, Velazquez-Campoy A, Rubio V, Perez B
. Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures. J Inherit Metab Dis. 2021; 45(2):318-333.
DOI: 10.1002/jimd.12461.
View